Filing Details
- Accession Number:
- 0001654954-21-011152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-15 17:00:45
- Reporting Period:
- 2021-10-13
- Accepted Time:
- 2021-10-15 17:00:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1040470 | Aehr Test Systems | AEHR | Instruments For Meas & Testing Of Electricity & Elec Signals (3825) | 942424084 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203324 | T Howard Slayen | C/O Aehr Test Systems 400 Kato Terrace Fremont CA 94539 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-13 | 10,000 | $2.06 | 249,090 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-10-13 | 18,219 | $2.06 | 267,309 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-10-13 | 2,500 | $20.47 | 264,809 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-10-13 | 2,500 | $20.45 | 262,309 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-10-13 | 10,000 | $0.00 | 10,000 | $2.06 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-10-13 | 18,219 | $0.00 | 18,219 | $2.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-11-21 | 2021-10-21 | No | 4 | M | Direct |
0 | 2014-11-21 | 2021-10-21 | No | 4 | M | Direct |
Footnotes
- One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
- One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter.